Dr Gavin Harris
Digital pathology is the reviewing of tissue slides on a computer monitor rather than using microscopes.
Validation Of Predictive Biomarkers For T-DM1 Activity In HER2+ Breast Cancer
Dr Barbara Lipert
The antibody-drug conjugate trastuzumab emtansine (T-DM1; Kadcyla) extends the survival of HER2-positive metastatic breast cancer patients.
Analysis Of Full-length Transcripts For Variant Classification In Breast Cancer
Dr Logan Walker
The future of successful genetic screening in New Zealand requires increased sensitivity and specificity of tests, and informed clinical management for high-risk breast cancer families.
Validation Of A Liquid Biopsy To Predict Recurrence In NZ Breast Cancer Patients
Dr Annette Lasham
Early detection of breast cancer recurrence is critical for saving lives. We have identified two molecules, found in the blood of 250 patients at the time of surgery for breast cancer, that were very good at predicting which of these women would have a relapse before five years.